EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PAD4 Inhibitor‐Functionalized Layered Double Hydroxide Nanosheets for Synergistic Sonodynamic Therapy/Immunotherapy Of Tumor Metastasis

Di Zhu, Yu Lu, Shuqing Yang, Tingting Hu, Chaoliang Tan iD, Ruizheng Liang, Yuji Wang

Advanced Science · 2024-07 · 11 (26)

DOI: 10.1002/advs.202401064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 06.05.2024. Verfasst von Di Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, College of Pharmaceutical Sciences of Capital Medical University, Beijing, 100069, P. R. China. Hauptthemen laut MEDLINE: Immunotherapy, Hydroxides, Ultrasonic Therapy. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Chinese Institutes for Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sonodynamic therapy (SDT) is demonstrated to trigger the systemic immune response of the organism and facilitate the treatment of metastatic tumors. However, SDT‐mediated neutrophil extracellular traps (NETs) formation can promote tumor cell spread, thus weakening the therapeutic effectiveness of metastatic tumors. Herein, the amorphous CoW‐layered double hydroxide (a‐CoW‐LDH) nanosheets are functionalized with a peptidyl arginine deiminase 4 (PAD4) inhibitor, i.e., YW3‐56, to construct a multifunctional nanoagent (a‐LDH@356) for synergistic SDT/immunotherapy. Specifically, a‐CoW‐LDH nanosheets can act as a sonosensitizer to generate abundant reactive oxygen species (ROS) under US irradiation. After loading with YW3‐56, a‐LDH@356 plus US irradiation not only effectively induces ROS generation and immunogenic cell death, but also inhibits the elevation of citrullinated histone H3 (H3cit) and the release of NETs, enabling a synergistic enhancement of anti‐tumor metastasis effect. Using 4T1 tumor model, it is demonstrated that combining a‐CoW‐LDH with YW3‐56 stimulates an anti‐tumor response by upregulating the proportion of immune‐activated cells and inducing polarization of M1 macrophages, and inhibits immune escape by downregulating the expression of PD‐1 on immune cells under US irradiation, which not only arrests primary tumor progression with a tumor inhibition rate of 69.5% but also prevents tumor metastasis with the least number of lung metastatic nodules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyHydroxidesUltrasonic TherapyAnimalsMiceDisease Models, AnimalProtein-Arginine Deiminase Type 4Reactive Oxygen SpeciesCell Line, TumorNeoplasm MetastasisNanostructuresFemaleMice, Inbred BALB CHumansExtracellular Traps

Stichwörter der Autor:innen

immunogenic cell deathimmunotherapylayered double hydroxidessonodynamic therapytumor metastasis

Substanzen

HydroxidesProtein-Arginine Deiminase Type 4Reactive Oxygen Species

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, College of Pharmaceutical Sciences of Capital Medical University, Beijing, 100069, P. R. China.
  • State Key Laboratory of Chemical Resource Engineering, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.
  • Department Electrical and Electronic Engineering, The University of Hong Kong, Pokfulam Road, Hong Kong SAR, 999077, P. R. China.
  • Quzhou Institute for Innovation in Resource Chemical Engineering, Quzhou, 324000, P. R. China.
  • Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing Laboratory of Biomedical Materials, Laboratory for Cl…

ORCID-Profile: Chaoliang Tan

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Chinese Institutes for Medical Research
  • Organized Scientific Research Program
  • Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support

Zitieren

APA

Zhu, D., Lu, Y., Yang, S., Hu, T., Tan, C., Liang, R., & Wang, Y. (2024). PAD4 Inhibitor‐Functionalized Layered Double Hydroxide Nanosheets for Synergistic Sonodynamic Therapy/Immunotherapy Of Tumor Metastasis. Advanced Science, 11(26). https://doi.org/10.1002/advs.202401064

Vancouver

Zhu D, Lu Y, Yang S, Hu T, Tan C, Liang R, et al. PAD4 Inhibitor‐Functionalized Layered Double Hydroxide Nanosheets for Synergistic Sonodynamic Therapy/Immunotherapy Of Tumor Metastasis. Advanced Science. 2024;11(26). doi:10.1002/advs.202401064

BibTeX
@article{Zhu2024,
  author = {Zhu, Di and Lu, Yu and Yang, Shuqing and Hu, Tingting and Tan, Chaoliang and Liang, Ruizheng and Wang, Yuji},
  title = {PAD4 Inhibitor‐Functionalized Layered Double Hydroxide Nanosheets for Synergistic Sonodynamic Therapy/Immunotherapy Of Tumor Metastasis},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {26},
  doi = {10.1002/advs.202401064}
}
Kostenlos starten →